Description
How It Works
ARA-290, also known as cibinetide, is an erythropoietin-derived peptide designed for tissue-protective and innate-repair signalling without the red-blood-cell stimulating effects associated with erythropoietin. It is generally positioned for nerve support, inflammation modulation, and regenerative support rather than hematopoietic use.
In practical use, ARA-290 is usually chosen where the goal is support for neuropathic pain, nerve repair, inflammation control, and longer-term recovery-focused protocols. It is particularly relevant where nerve irritation, altered sensation, or inflammatory tissue stress are part of the picture.
Cycle length: For protocols 1 or 2, use for 6 – 12 weeks, then pause for 4 weeks before repeating if needed.
For protocol 3, use for 4 – 6 weeks, then pause for 4 weeks before repeating if needed.
Each cartridge contains 3mL bacteriostatic water (300 units)
Dosage scale with pen
| 10 units |
1.00mg |
30 units |
3.00mg |
| 20 units |
2.00mg |
40 units |
4.00mg |
KEEP REFRIGERATED.
Expected Outcomes
ARA-290 30mg is typically used where the goal is improved nerve comfort, better inflammatory control, and stronger regenerative support over time.
- Support for neuropathic pain-focused protocols
- Support for nerve repair and regeneration planning
- Improved alignment with inflammation-modulation goals
- Better fit within structured recovery-focused protocols
- Gradual benefit building over the first few weeks
Cautions and Warnings
Not suitable for people under the age of 18.
Not suitable during pregnancy.
Not suitable while breastfeeding.
Related Products
- BPC-157 — tissue-support pairing
- TB-500 — recovery-focused pairing
- KPV — useful where inflammatory skin or tissue support is a priority
- MOTS-C — metabolic and resilience support pairing